These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 2505730)

  • 1. The addition of lithium to carbamazepine. Antidepressant efficacy in treatment-resistant depression.
    Kramlinger KG; Post RM
    Arch Gen Psychiatry; 1989 Sep; 46(9):794-800. PubMed ID: 2505730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lithium carbonate augmentation of antidepressant treatment. An effective prescription for treatment-refractory depression.
    Heninger GR; Charney DS; Sternberg DE
    Arch Gen Psychiatry; 1983 Dec; 40(12):1335-42. PubMed ID: 6418110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The comparative efficacy and safety of carbamazepine versus lithium: a randomized, double-blind 3-year trial in 83 patients.
    Placidi GF; Lenzi A; Lazzerini F; Cassano GB; Akiskal HS
    J Clin Psychiatry; 1986 Oct; 47(10):490-4. PubMed ID: 3093468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addition of monoamine oxidase inhibitors to carbamazepine: preliminary evidence of safety and antidepressant efficacy in treatment-resistant depression.
    Ketter TA; Post RM; Parekh PI; Worthington K
    J Clin Psychiatry; 1995 Oct; 56(10):471-5. PubMed ID: 7559374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lithium carbonate addition in tricyclic antidepressant-resistant unipolar depression. Correlations with the neurobiologic actions of tricyclic antidepressant drugs and lithium ion on the serotonin system.
    de Montigny C; Cournoyer G; Morissette R; Langlois R; Caillé G
    Arch Gen Psychiatry; 1983 Dec; 40(12):1327-34. PubMed ID: 6418109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative prophylactic efficacy of lithium, carbamazepine, and the combination in bipolar disorder.
    Denicoff KD; Smith-Jackson EE; Disney ER; Ali SO; Leverich GS; Post RM
    J Clin Psychiatry; 1997 Nov; 58(11):470-8. PubMed ID: 9413412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiation of antidepressants with lithium or carbamazepine in treatment-resistant depression.
    Rybakowski JK; Suwalska A; Chlopocka-Woźniak M
    Neuropsychobiology; 1999 Sep; 40(3):134-9. PubMed ID: 10494048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidepressant effects of carbamazepine.
    Post RM; Uhde TW; Roy-Byrne PP; Joffe RT
    Am J Psychiatry; 1986 Jan; 143(1):29-34. PubMed ID: 3510572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adding lithium to antidepressant therapy: factors related to therapeutic potentiation.
    Rybakowski J; Matkowski K
    Eur Neuropsychopharmacol; 1992 Jun; 2(2):161-5. PubMed ID: 1633434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Addition of lithium carbonate to carbamazepine: hematological and thyroid effects.
    Kramlinger KG; Post RM
    Am J Psychiatry; 1990 May; 147(5):615-20. PubMed ID: 2109539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lithium as an adjunct in the treatment of major depression.
    Browne M; Lapierre YD; Hrdina PD; Horn E
    Int Clin Psychopharmacol; 1990 Apr; 5(2):103-10. PubMed ID: 2116474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lithium potentiation of tricyclic antidepressants following lack of T3 potentiation.
    Garbutt JC; Mayo JP; Gillette GM; Little KY; Mason GA
    Am J Psychiatry; 1986 Aug; 143(8):1038-9. PubMed ID: 3089033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematological effects of lithium potentiation of carbamazepine in patients with affective illness.
    Joffe RT
    Int Clin Psychopharmacol; 1988 Jan; 3(1):53-7. PubMed ID: 3128600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The benefit of lithium carbonate adjunct in refractory depression--fact or fiction?
    Kantor D; McNevin S; Leichner P; Harper D; Krenn M
    Can J Psychiatry; 1986 Jun; 31(5):416-8. PubMed ID: 3089576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lithium augmentation in treatment-resistant depression: meta-analysis of placebo-controlled studies.
    Bauer M; Dopfmer S
    J Clin Psychopharmacol; 1999 Oct; 19(5):427-34. PubMed ID: 10505584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variability of response to lithium augmentation in refractory depression.
    Price LH; Charney DS; Heninger GR
    Am J Psychiatry; 1986 Nov; 143(11):1387-92. PubMed ID: 3096155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid antidepressant effect of addition of lithium to tranylcypromine.
    Tariot PN; Murphy DL; Sunderland T; Mueller EA; Cohen RM
    J Clin Psychopharmacol; 1986 Jun; 6(3):165-7. PubMed ID: 3711366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lithium potentiation of antidepressant treatment.
    Louie AK; Meltzer HY
    J Clin Psychopharmacol; 1984 Dec; 4(6):316-21. PubMed ID: 6511998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rational polypharmacy in the bipolar affective disorders.
    Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M
    Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lithium augmentation in antidepressant-resistant patients. A quantitative analysis.
    Austin MP; Souza FG; Goodwin GM
    Br J Psychiatry; 1991 Oct; 159():510-4. PubMed ID: 1836411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.